136 related articles for article (PubMed ID: 3664361)
1. Sex- and species-related differences in the biotransformation of isosorbide dinitrate by various tissues of the rabbit and rat.
Tam GS; Marks GS; Brien JF; Nakatsu K
Can J Physiol Pharmacol; 1987 Jul; 65(7):1478-83. PubMed ID: 3664361
[TBL] [Abstract][Full Text] [Related]
2. Determination of isosorbide dinitrate biotransformation in various tissues of the rabbit by capillary column gas-liquid chromatography.
Tam GS; Nakatsu K; Brien JF; Marks GS
Biopharm Drug Dispos; 1987; 8(1):37-45. PubMed ID: 3580511
[TBL] [Abstract][Full Text] [Related]
3. Patterns of isosorbide dinitrate and glyceryl trinitrate metabolites formed by selected segments of the rabbit gastrointestinal tract.
Tam GS; MacMillan H; Bennett BM; Marks GS; Brien JF; Nakatsu K
Can J Physiol Pharmacol; 1988 Feb; 66(2):166-70. PubMed ID: 3130974
[TBL] [Abstract][Full Text] [Related]
4. Effect of 5-isosorbide mononitrate on isosorbide dinitrate-induced relaxation of rabbit aortic rings.
Bennett BM; Tam GS; Van Alstyne K; Brien JF; Nakatsu K; Marks GS
Can J Physiol Pharmacol; 1984 Sep; 62(9):1194-7. PubMed ID: 6498631
[TBL] [Abstract][Full Text] [Related]
5. Biotransformation of glyceryl trinitrate and isosorbide dinitrate in vascular smooth muscle made tolerant to organic nitrates.
Slack CJ; McLaughlin BE; Brien JF; Marks GS; Nakatsu K
Can J Physiol Pharmacol; 1989 Nov; 67(11):1381-5. PubMed ID: 2516767
[TBL] [Abstract][Full Text] [Related]
6. Contribution of isosorbide-5-mononitrate, a major metabolite of isosorbide dinitrate (ISDN), to the hemodynamic effect of ISDN administered orally in conscious dogs.
Kogi K; Satoh T
Jpn J Pharmacol; 1987 Jul; 44(3):249-57. PubMed ID: 3656782
[TBL] [Abstract][Full Text] [Related]
7. Concentrations of isosorbide dinitrate, isosorbide-2-mononitrate and isosorbide-5-mononitrate in human vascular and muscle tissue under steady-state conditions.
Schneider W; Menke G; Heidemann R; Satter P; Kaltenbach M; Rietbrock N
Eur J Clin Pharmacol; 1990; 38(2):145-7. PubMed ID: 2338111
[TBL] [Abstract][Full Text] [Related]
8. Comparison of the time to onset of action on myocardial ischaemia following intravenous administration of isosorbide dinitrate and 5-isosorbide mononitrate in Chinese patients.
Wu ZG; Li JN; Fan M; Shang YK; Zhang YW; Bai J; Ding R; Cheng JM; Liang C
Arzneimittelforschung; 2004; 54(5):275-9. PubMed ID: 15212189
[TBL] [Abstract][Full Text] [Related]
9. Plasma disposition and hemodynamic effects of a single oral dose of isosorbide dinitrate in human males and females.
Nakatsu K; Brien JF; Savard G; Toffelmire EB; Abdollah H; Bennett BM; Marks GS
Biopharm Drug Dispos; 1992 Jul; 13(5):357-67. PubMed ID: 1498268
[TBL] [Abstract][Full Text] [Related]
10. Sex-related difference in the metabolism of isosorbide dinitrate following incubation in human blood.
Bennett BM; Twiddy DA; Moffat JA; Armstrong PW; Marks GS
Biochem Pharmacol; 1983 Dec; 32(24):3729-34. PubMed ID: 6661248
[TBL] [Abstract][Full Text] [Related]
11. Absorption and excretion of isosorbide dinitrate and isosorbide-2-mononitrate in dogs.
Cayen MN; Hicks D; Karounis J; Dvornik D
J Pharm Pharmacol; 1983 May; 35(5):312-6. PubMed ID: 6134800
[TBL] [Abstract][Full Text] [Related]
12. Isosorbide dinitrate disposition in the rat: metabolite pharmacokinetics and interactions.
Morrison RA; Fung HL
J Pharmacol Exp Ther; 1984 Oct; 231(1):124-30. PubMed ID: 6491969
[TBL] [Abstract][Full Text] [Related]
13. Nitro compounds (isosorbide dinitrate, 5-isosorbide mononitrate and glyceryl trinitrate) on the femoral vein and femoral artery.
Toyoda J; Hisayama T; Takayanagi I
Gen Pharmacol; 1986; 17(1):89-91. PubMed ID: 3081404
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of angiogenesis, tumour growth and metastasis by the NO-releasing vasodilators, isosorbide mononitrate and dinitrate.
Pipili-Synetos E; Papageorgiou A; Sakkoula E; Sotiropoulou G; Fotsis T; Karakiulakis G; Maragoudakis ME
Br J Pharmacol; 1995 Sep; 116(2):1829-34. PubMed ID: 8528567
[TBL] [Abstract][Full Text] [Related]
15. [Plasma levels of isosorbide dinitrate and its metabolites during intravenous infusion in surgical patients--effect of preoperative administration of isosorbide dinitrate].
Murakawa T; Hashimoto Y; Sato T; Takagi H; Kushikata T; Araki I; Kou H; Kimura F; Matsuki A
Masui; 1993 Feb; 42(2):225-32. PubMed ID: 8437354
[TBL] [Abstract][Full Text] [Related]
16. [Pharmacokinetics of isosorbide dinitrate studied by the extrapolation model].
Matsumoto J; Ohtaka K; Enzan K; Koizumi A; Suzuki M
Masui; 1994 May; 43(5):689-96. PubMed ID: 8015156
[TBL] [Abstract][Full Text] [Related]
17. [Pharmacokinetics of isosorbide dinitrate examined by physiologically-based pharmacokinetic model].
Matsumoto J
Masui; 1997 Jul; 46(7):926-33. PubMed ID: 9251507
[TBL] [Abstract][Full Text] [Related]
18. Influence of electric foot shock on pharmacokinetics of isosorbide dinitrate subcutaneously administered to rats.
Gomita Y; Furuno K; Araki Y
Jpn J Pharmacol; 1989 Sep; 51(1):132-5. PubMed ID: 2810934
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetics of isosorbide dinitrate and isosorbide-5-mononitrate.
Schaumann W
Int J Clin Pharmacol Ther Toxicol; 1989 Sep; 27(9):445-53. PubMed ID: 2681004
[TBL] [Abstract][Full Text] [Related]
20. The Endothelin Receptor Antagonist Macitentan Improves Isosorbide-5-Mononitrate (ISMN) and Isosorbide Dinitrate (ISDN) Induced Endothelial Dysfunction, Oxidative Stress, and Vascular Inflammation.
Steven S; Oelze M; Hausding M; Roohani S; Kashani F; Kröller-Schön S; Helmstädter J; Jansen T; Baum C; Iglarz M; Schulz E; Münzel T; Daiber A
Oxid Med Cell Longev; 2018; 2018():7845629. PubMed ID: 30687454
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
